Diseases, Conditions, Syndromes

Mavyret approved as 8-week treatment for hep C, compensated cirrhosis

(HealthDay)—Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through ...

Medications

Academics call for structured drug monitoring in care homes

Professor Sue Jordan from the University's College of Human and Health Sciences led the research which is newly published in the PLOS ONE journal. The study showed how care home residents' adverse side effects were picked ...

Medications

Women and elderly at higher risk of dangerous drug interactions

A new study led by researchers at Indiana University has found that women and older adults who use multiple prescription drugs are significantly more likely to be prescribed pills whose combination produces dangerous side ...

Diabetes

FDA approves first noninjection glucagon therapy

(HealthDay)—The U.S. Food and Drug Administration has approved the first noninjection glucagon therapy for emergency treatment of severe hypoglycemia, the agency announced late yesterday.

Medical research

Encephalitis identified as rare toxicity of immunotherapy treatment

After a cancer patient receiving an immunotherapy developed encephalitis and died 18 months into treatment, researchers at Vanderbilt-Ingram Cancer Center (VICC) investigated why the complication occurred, performing a molecular ...

page 1 from 18